eCommons at Roseman University
Not a member yet
635 research outputs found
Sort by
The Opportunities and Barriers Surrounding the Use of Digital Health and Telemedicine in Sub-Saharan Africa
Full text linkEffectiveness of test-enhanced learning in undergraduate dental education: a systematic review
Full text linkOrthodontic Correction of Bimaxillary Protrusion Using MBT and Frictionless Retraction: A case report
Full text linkThe present poster is about a case report of class I bimaxillary protrusion patient, orthodontically treated by extracting all four premolars and retracted using frictionless mechanics (Tear drop loop)
Exploring the Therapeutic Potential of Resveratrol in Substance Use Disorders: A Systematic Review of its Effects on KCC2 Expression
No full textInvestigating the Impact of Tirzepatide Treatment on Alcohol and Cigarette Consumption
Full text linkCLINICAL EFFECTIVENESS OF BIODENTINE IN ADULT PULPOTOMY PROCEDURES: A SYSTEMATIC REVIEW
Full text linkThis systematic review aimed to evaluate the evidence from randomised clinical trials for the effectiveness of pulpotomy using Biodentine in adult humans, focusing on clinical outcomes of pain after the procedure and radiographic evaluations
Impact of N-acetylcysteine in non-acetaminophen-induced acute liver failure: A retrospective analysis
Full text linkN-acetylcysteine (NAC) has been widely used in the treatment of liver failure secondary to acetaminophen overdose. At Valley Hospital Medical Center (VHMC) and other Valley Health System hospitals, NAC has been used as an off-label treatment for non-acetaminophen-induced acute liver failure (NAI-ALF) and ischemic hepatitis. Studies have shown NAC is safe for use in NAI-ALF and may provide a survival benefit in native liver without transplantation. While some evidence suggests potential benefits of NAC for NAI-ALF, lack of robust, high-quality studies limits its widespread adoption and routine use. The objective of this study is to evaluate the effectiveness of NAC in reducing ALT and AST within 72 hours in patients with NAI-ALF
Effect of Routine Third Trimester Ultrasounds on Maternal Mental Health in Low-Risk Population in Utah
Full text linkPurpose: One in five pregnant women in the United States experience a maternal mental health condition. Within Utah from 2018-2022, during pregnancy, 22.7% of women experienced depression and 31.6% experienced anxiety, and 15.1% experienced postpartum depression. These data represent a prevalence higher than the national average. Third trimester ultrasound (TTUS) is not a standard of care performed in the United States currently. Previous TTUS research has mainly focused on the financial burden and birth outcomes rather than maternal mental health. Literature on first trimester ultrasound has demonstrated a notable impact on maternal mental health, but these outcomes within the third trimester and after birth are limited. The purpose of this study is to determine the effect of TTUS on mental health outcomes for expectant mothers.
Methods: Pregnant women will be recruited from Utah and will complete the informed consent process. TTUS will occur after 28 weeks of gestation at the Noorda College of Osteopathic Medicine. The subjects will complete the PHQ-9, GAD-7, and the MSPSS during the ultrasound appointment, 6 weeks postpartum, and 6 months postpartum. Statistical analysis will employ multivariate repeated measures ANOVA to determine the impact of the third trimester ultrasound on maternal mental health outcomes.
Results: Work in Progress: We hypothesize that individuals who receive a third trimester ultrasound will exhibit decreases in standardized mental health scores compared to baseline.
Conclusion: Work in Progress: We aim to prove there is an improvement in maternal mental health with routine third trimester ultrasounds
